Knightscope (NASDAQ: KSCP) is pursuing a bigger prize than selling robots: it is assembling an integrated, technology-enabled security service designed to combine autonomous machines, AI software, remote monitoring and licensed human agents under one accountable operating model.
There is no shortage of…
Alpha Cognition Inc. (NASDAQ: ACOG) has moved meaningfully beyond the familiar small-cap biotech ritual of promising future potential. Since CEO Michael McFadden’s January 15, 2026 Tribe Public luncheon presentation during the J.P. Morgan Healthcare Conference week in San Francisco, the company has paired…
Knightscope, Inc. (NASDAQ: KSCP) is making a broader case than “robots on patrol.” With record second-quarter revenue, an expanding national client base, new AI-driven security capabilities and an integrated model that joins autonomous machines with trained human professionals, the company is positioning itself…
Tribe Public CEO Presentation & Q&A: Hosted Friday, August 21
Tribe Public hosted its CEO Presentation and Q&A webinar, “Food Shouldn’t Hurt: EOE, Eupraxia, and a Promising New Treatment Approach,” featuring James Helliwell, MD, Chief Executive Officer of Eupraxia Pharmaceuticals Inc. (NASDAQ:…
Seven Boson Group’s expansion within the Google Cloud partner ecosystem and its increasingly defined sovereign-AI strategy offer a bullish picture of a company aiming to participate in a more mature phase of the artificial-intelligence buildout. The premise is compelling: as AI moves…
Amwell, Inc. (NYSE: AMWL, $12.40, up +152.55% YTD) is building a more investable telehealth narrative: less pandemic-era novelty, more enterprise healthcare infrastructure. Its second-quarter results suggest the company is translating a broad digital-care footprint into a steadier mix of recurring subscription revenue,…
The biotechnology market has a habit of demanding patience right up until it abruptly decides to reward it. Moderna, Inc. (NASDAQ: MRNA) recently reminded investors of that rule as enthusiasm around its personalized melanoma-vaccine program with Merck & Co., Inc. (NYSE: MRK)…
For patients with eosinophilic esophagitis, eating can become an exercise in calculated risk rather than a simple pleasure. For Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX), that burden represents both an urgent medical problem and a potentially compelling opportunity to prove that…
U.S. equities finished lower on Tuesday, August 11, 2026, extending a modest two-session pullback from recent record levels. Concerns that a resolution to the U.S.-Iran standoff may take longer than hoped helped keep oil prices elevated, while investors positioned cautiously ahead of…
U.S. equities finished modestly lower on Monday as a sharp move higher in crude oil renewed inflation concerns ahead of this week’s key U.S. inflation data. The session reflected measured risk reduction rather than broad capitulation: volatility rose, technology lagged, and energy…
